January 2010 - Volume 24 - Issue 2
pp: N3,163-330




Concise Communications


Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recovery.

Woelk, Christopher H; Beliakova-Bethell, Nadejda; Goicoechea, Miguel; More

AIDS . 24(2):217-222, January 2010.


The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml.

Arribas, Jose R; Horban, Andrzej; Gerstoft, Jan; More

AIDS . 24(2):223-230, January 2010.

Concise Communication






1 2 3 4 5